H3K18 lactylation-mediated SIX1 upregulation contributes to silica-induced epithelial-mesenchymal transition in airway epithelial cells

Toxicology. 2025 Jun:514:154109. doi: 10.1016/j.tox.2025.154109. Epub 2025 Mar 4.

Abstract

Silica exposure-induced airway epithelial-mesenchymal transition (EMT) is a critical pathological process in pulmonary fibrosis. This study investigated the role of NLRP3 inflammasome, glycolysis, and histone lactylation in silica-induced EMT of human bronchial epithelial cells (16HBE). Silica exposure activated NLRP3 inflammasome, enhanced glycolysis and H3K18 lactylation, as well as induced EMT in 16HBE cells. Selective inhibition of NLRP3 inflammasome with MCC950, blockade of the interleukin 1 (IL-1) receptor with AF12198, or suppression of lactate production with oxamate effectively reduced glycolysis-mediated histone lactylation and mitigated silica-induced EMT. Moreover, silica-induced upregulation of PFKFB3, a key enzyme of glycolysis, was significantly mitigated by MCC950 or AF12198. Cut&Tag analysis revealed silica treatment led to H3K18 lactylation enrichment at transcription start sites (TSS), particularly within the promoter region of the sine oculis homeobox 1 (SIX1), which enhanced transcription of SIX1, a key transcription factor involved in EMT. Consistently, inhibition of histone lactylation by the histone acetyltransferase P300 inhibitor A-485 suppressed silica-induced SIX1 expression and EMT. These findings indicate that silica activates NLRP3 inflammasome and promotes interleukin 1β (IL-1β) production, thereafter enhancing PFKFB3-mediated glycolysis by IL-1 receptor. Lactate accumulation by glycolysis enhances H3K18 lactylation at the TSS facilitating expression of SIX1. Together, this inflammation-glycolysis-lactylation cascade involved in EMT provides new insights into the molecular mechanisms underlying silica-induced pulmonary fibrosis.

Keywords: Epithelial-mesenchymal transition (EMT); Glycolysis; Histone lactylation; NLRP3 inflammasome; SIX1; Silica.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchi / drug effects
  • Bronchi / metabolism
  • Bronchi / pathology
  • Cell Line
  • Epithelial Cells* / drug effects
  • Epithelial Cells* / metabolism
  • Epithelial Cells* / pathology
  • Epithelial-Mesenchymal Transition* / drug effects
  • Glycolysis / drug effects
  • Histones* / metabolism
  • Homeodomain Proteins* / genetics
  • Homeodomain Proteins* / metabolism
  • Humans
  • Inflammasomes / drug effects
  • Inflammasomes / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Phosphofructokinase-2 / genetics
  • Phosphofructokinase-2 / metabolism
  • Silicon Dioxide* / toxicity
  • Up-Regulation / drug effects

Substances

  • Silicon Dioxide
  • Histones
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Homeodomain Proteins
  • Inflammasomes
  • NLRP3 protein, human
  • PFKFB3 protein, human
  • Phosphofructokinase-2